IP Library Granted Patent US 9,522,277
Granted Patent B2
US 9,522,277 · App. 12/180,911 · Granted Dec 20, 2016

Lead integrity testing triggered by sensed signal saturation

Inventor: Bruce D. Gunderson (Plymouth, MN)
Assignee: Medtronic, Inc.
A61N1/3706A61N1/3702A61N2001/083
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,522,277
App. No.
12/180,911
Granted
Dec 20, 2016
Kind
B2
Abstract

Techniques for performing a lead integrity test in response to, e.g., during or after saturation of a sensed signal, e.g., a cardiac electrogram (EGM) signal, are described. A lead integrity test may comprise one or more impedance measurements for one or more leads. Possible causes of saturation of a sensed signal include lead conductor or connector issues, or other lead related conditions. A lead integrity test triggered in response to the saturation may be able to detect any lead related condition causing the saturation. A lead integrity test triggered in response to the saturation may advantageously be able to detect an intermittent lead related condition, due to the temporal proximity of the test to the saturation.

Claims (11)

1. A system comprising:

an implantable medical lead comprising one or more electrodes; an implantable medical device (IMD) coupled to the lead that senses a physiological signal of a patient via the electrodes; and a processor that configured to:

detect saturation of the signal; and

control the IMD to perform a lead impedance measurement of the implantable medical lead in response to the detection;

wherein the processor is configured to determine whether the signal is saturated for at least one of a threshold duration or a threshold number of samples, and controls the IMD to perform the lead integrity test in response to the determination.

2. A system comprising:

an implantable medical lead comprising one or more electrodes; an implantable medical device (IMD) coupled to the lead that senses a physiological signal of a patient via the electrodes; and a processor that configured to:

detect saturation of the signal; and

control the IMD to perform a lead impedance measurement of the implantable medical lead in response to the detection;

wherein the IMD comprises a clamp circuit that clamps the signal and provides an indication when the signal is clamped, and

wherein the processor is configured to detect saturation of the signal based on the indication.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2008
From: GUNDERSON, BRUCE D.
To: MEDTRONIC, INC.
Reel/Frame 021665/0279 →
Continuity (1)
Related Publication 20100023084A1 · Jan 28, 2010